Reference
Alexandre C, et al. Neurotuberculosis Secondary to Adalimumab. Inflammatory Bowel Diseases 23 (Suppl. 1): S13, Feb 2017. Available from: URL: http://doi.org/10.1097/01.MIB.0000512548.59553.01 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1967, 17 (2023). https://doi.org/10.1007/s40278-023-43824-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-43824-8